-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.

Zhitongcaijing·09/14/2026 18:17:11
Listen to the news
Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.